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Abstract
Background: Appropriate footwear for individuals with diabetes but no ulceration history could reduce the risk of
first ulceration. However, individuals who deem themselves at low risk are unlikely to seek out bespoke footwear
which is personalised. Therefore, our primary aim was to investigate whether group-optimised footwear designs,
which could be prefabricated and delivered in a retail setting, could achieve appropriate pressure reduction, or
whether footwear selection must be on a patient-by-patient basis. A second aim was to compare responses to
footwear design between healthy participants and people with diabetes in order to understand the transferability
of previous footwear research, performed in healthy populations.
Methods: Plantar pressures were recorded from 102 individuals with diabetes, considered at low risk of ulceration.
This cohort included 17 individuals with peripheral neuropathy. We also collected data from 66 healthy controls.
Each participant walked in 8 rocker shoe designs (4 apex positions × 2 rocker angles). ANOVA analysis was then
used to understand the effect of two design features and descriptive statistics used to identify the group-optimised
design. Using 200 kPa as a target, this group-optimised design was then compared to the design identified as the
best for each participant (using plantar pressure data).
Results: Peak plantar pressure increased significantly as apex position was moved distally and rocker angle reduced
(p < 0.001). The group-optimised design incorporated an apex at 52% of shoe length, a 20° rocker angle and an
apex angle of 95°. With this design 71–81% of peak pressures were below the 200 kPa threshold, both in the full
cohort of individuals with diabetes and also in the neuropathic subgroup. Importantly, only small increases (<5%) in
this proportion were observed when participants wore footwear which was individually selected. In terms of
optimised footwear designs, healthy participants demonstrated the same response as participants with diabetes,
despite having lower plantar pressures.
Conclusions: This is the first study demonstrating that a group-optimised, generic rocker shoe might perform
almost as well as footwear selected on a patient by patient basis in a low risk patient group. This work provides a
starting point for clinical evaluation of generic versus personalised pressure reducing footwear.
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Background
Van Netten et al. [1] highlighted that studies investigat-
ing “the specific role of therapeutic footwear in preventing
a first foot ulcer in at-risk patients with diabetes are
lacking, and are therefore urgently needed”. Indeed, use
of appropriate footwear by people with diabetes without
prior ulceration is widely advocated [2–4] and motivated
by a need to reduce plantar pressures that are one of the
many risk factors for ulceration [5, 6]. In addition to re-
ducing plantar pressure, however, changes in footwear
habits prior to first ulceration would allow more time
for footwear related behaviour change to become per-
manent prior to a serious foot or limb threatening event.
At that stage adherence with footwear advice or pre-
scriptions is known to affect ulcer healing and risk of re-
ulceration, but effective behaviour change is often not
achieved. This was demonstrated in a recent trial which
observed a significant (19%) reduction in re-ulceration
at 18-month follow, but only in the subgroup with good
adherence and who wore customised footwear as recom-
mended [7]. Changes in footwear choices and use prior
to first ulceration might therefore mitigate the risk of a
first ulcer by reducing pressure and improve longer term
adherence if ulcers do occur.
Prior to investigating the potential reduction in the
risk of a first ulcer due to pressure relieving footwear as
Van Netten advocates [1], it is important to optimise the
design of the footwear. Indeed, following a systematic re-
view, Bus et al. [8] called for more standardised proce-
dures to inform the design of footwear used in ulcer
prevention. To optimise an intervention it is important
to have an objective measure of performance. In cases of
re-ulceration, reducing plantar pressures to <200 kPa
has been the target for optimising footwear design [9–
12]. A corresponding pressure target does not yet exist
for first ulceration, but 200 kPa forms a logical initial
target. Unfortunately, use of this threshold in practice
relies on the use of pressure measurement at the point
of footwear provision [7], and this may not always be
feasible. This is especially true prior to first ulceration,
when many of the footwear choices made, and impli-
cated in subsequent ulceration, occur in a retail rather
than a health care setting.
A preferable approach would be use prefabricated
footwear incorporating a standardised design (i.e. same
for all patients) which is known to reduce pressures
<200 kPa for the majority of individuals. This will be re-
ferred to as group-optimised footwear. However, no such
group-optimised design exists at present and current
evidence for footwear achieving the <200 kPa threshold
relates only to footwear selected/customised using indi-
vidual plantar pressure data [7, 10, 12]. We refer to this
as personalised footwear. Producing personalised foot-
wear for individual patients is expensive and unlikely to
be justified prior to a first ulcer unless there are signifi-
cant risk factors. Therefore, in order to meet the
200 kPa target using footwear to prevent a first ulcer, it
is important to understand whether group-optimised
footwear that could be mass produced might suffice or
whether personalised footwear is required.
In terms of the most appropriate footwear outsole de-
signs for pressure relief, most clinical studies have investi-
gated shoes with some form of stiff rocker outsole [7, 10].
This design has been shown to reduce peak plantar pres-
sures at high risk sites [13]. However, a full description of
the design features of the rocker outsole, or indeed the
rest of the shoe, is often limited [14]. This is important be-
cause it limits our understanding of the relationship be-
tween design features (independent variable) and changes
of pressure (dependent variable), limiting our ability to op-
timise designs for groups of patients or individual patients.
Furthermore, the degree of offloading in each anatomical
area is strongly influenced by the precise geometry of the
rocker outsole [15, 16]. For example, our earlier work
showed that altering the rocker sole apex angle by only
10–20°, can have a critical effect on the degree of offload-
ing under the 1st metatarsophalangeal (MTP) joint [16].
A further issue is that several previous studies investi-
gating pressure reducing footwear intended for people
with diabetes have in fact involved only healthy individ-
uals [15, 17, 18]. There are known differences between
the gait and feet of those with and without diabetes [19]
and the transferability of results has not been tested.
Therefore, three issues need to be addressed. Firstly, we
need to better understand the systematic effect of chan-
ging different rocker shoe design features on plantar pres-
sure. With this we could propose group-optimised designs
which would be used in prefabricated footwear aimed at
reducing pressure beneath the 200 kPa threshold. Sec-
ondly, we need to understand the extent to which this
group-optimised footwear meets the <200 kPa target com-
pared to personalised footwear designs. Thirdly, since pre-
vious research has often assumed results from healthy
participants can be transferred to those with diabetes, we
need to compare footwear effects in healthy and diabetes
populations.
Methods
Participants
Subjects with diabetes were recruited at two sites: the Uni-
versity of Salford (UK) and the German Sport University.
At both sites participants were identified through primary
care clinics and through advertisement in the community.
Inclusion criteria were age ≥ 18 and medically confirmed
diagnosis of type 1 or type 2 diabetes at least 6 month
prior to enrolment on the study. Exclusion criteria were
any current/history of foot ulceration or any foot deform-
ity/medical foot condition that prevented the wearing of
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off-the-shelf therapeutic footwear. Healthy participants
were recruited via community advert and required to have
no medical diagnosis of diabetes or current musculoskel-
etal pain. All subjects provided written consent to partici-
pate in the study after appropriate ethical approval had
been obtained (UK NRES 10/H1013/32). Sensation loss in
the participants with diabetes was assessed using a 10 g
monofilament at 5 locations (hallux, 1st MTP, 5th Meta-
tarsal head (MTH), 5th toe and styloid process) [20].
Footwear and plantar pressure measurement
We sought to optimise the curved rocker outsole profile
[13]. Although personalised therapeutic footwear has a
wide range of different features that can be modified,
this study focused on the outsole geometry of the rocker
profile. This geometry can be described by three inde-
pendent design features: apex angle, apex position and
rocker angle [16] (Fig. 1). Apex angle and position define
the orientation (relative to the long axis of the shoe) and
position (% of shoe length) of a theoretical mediolateral
line where the outsole begins to curve upwards under
the forefoot. Our previous study demonstrated that an
apex angle of 95° was appropriate for footwear designed
to offload high risk regions of the forefoot [16] and was
used for all footwear.
Previous research has shown that varying apex pos-
ition can have a pronounced effect on peak plantar pres-
sure [15, 16]. Furthermore, modifying apex position for
each individual patient is one customisation option avail-
able when aiming to reduce plantar pressure [12]. We
therefore studied apex positions of 52, 57, 62 and 67% of
shoe length. The precise choice was motivated by our
previous study [16] which showed marked plantar pres-
sure increases when apex position was increased to 70%
of shoe length.
Rocker angle is the angle between the floor and sole
under the toe area (Fig. 1). Previous research has dem-
onstrated that plantar pressure decreases as rocker angle
is increased [15, 16] and increasing rocker angle is also a
customisation option [12]. However, increasing the
rocker angle from 15° to 20° has a pronounced effect on
the appearance of the shoe as the thickness of the out-
sole must be increased. It is therefore possible that use
of a 20°rocker angle would reduce adherence especially
if the footwear was to be used to prevent a first ulcer
(when motivation for a change in footwear habits might
be lower than once ulceration has been experienced).
Furthermore, our previous research suggests that the
benefits of increasing rocker angle above 15° may be
marginal, especially if the apex position is chosen appro-
priately [16]. Therefore, we studied a 15° rocker angle
(aesthetic design) and a 20° rocker angle (less aesthetic
design) in the hope of achieving the target pressures in
the former.
A total of eight shoes were designed in which rocker
angle (15° and 20°) and apex positon (52, 57, 62 and
67%) were independently varied. All footwear was manu-
factured with the same outsole thickness (Fig. 1) suffi-
cient to accommodate a 20° rocker angle at all apex
positions. This meant that the outsole of some designs
(especially those with a 15° rocker) was unnecessarily
thick but ensured that all shoes were of the same weight.
In addition, a control shoe was designed with exactly the
same upper as the rocker footwear but with a flexible
outsole, similar to that of a running shoe [21]. The out-
sole of all rocker footwear was manufactured using EVA
(ethyl vinyl acetate) and incorporated a 5 mm thick layer
of folex which ensured that the outsole was rigid. All
footwear were produced by Duna® (Italy) using CAD/
CAM technology.
For each of the nine shoes, in-shoe plantar pressure
was collected using Novel Pedar-X system (50 Hz) whilst
participants walked at 1 m/s along a 20 m walkway.
Speed was monitored during each trial using optical tim-
ing gates and only those trials within 10% of the target
speed used for further analysis. Shoe order was rando-
mised, using a custom Matlab program, and participants
Fig. 1 a Schematic to illustrate rocker angle (RA), apex position and
apex angle. Apex position was varied by moving point A proximally
or distally and a corresponding adjustment made to the position of
point B to ensure a consistent rocker angle. b Example rocker shoe
with RA = 20°
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completed a familiarisation period of three-four minutes
before data collection. A minimum of 25 steps was col-
lected for each shoe. Following collection, the data was
visually checked to identify the steps at the start and end
of each walking trial which were then removed. Peak
plantar pressures were calculated for each shoe design in
three high-risk [10] regions: 1st metatarsophalangeal
(MTP) joint, 2-4th metatarsal heads (MTH) and hallux.
The Pedar sensors corresponding to each region were
defined following Cavanagh et al. [22] and the peak pres-
sures, calculated for each region, averaged across all
steps to give a single value for each region and shoe.
This process was repeated across all participants using
custom Matlab software. The statistical analysis (out-
lined below) showed similar trends for both the left and
right sides and therefore only data from the left side are
presented in this paper.
Statistical analysis
A two-way ANOVA model with repeated measures was
used, in each anatomical region, to explore the effect of
apex position and rocker angle on plantar pressure in the
people with diabetes. This analysis was used to test for
main effects of apex position and rocker angle and also to
identify any possible interactions. If significant differences
in main effects were observed, pairwise differences were
investigated using a Bonferroni correction for multiple
comparisons. Before testing, all data was checked for nor-
mality and homogeneity of variance. A significance level
of α < 0.01 was chosen for all ANOVA analyses.
An optimal apex position was then identified, from de-
scriptive statistics, as that which minimised pressures for
the largest proportion of individuals with diabetes. This
optimal position was taken to be the group-optimised
design. Given our focus on two separate rocker angles
(RA) and concerns over the aesthetics of the larger
rocker angle, a group-optimised design was defined sep-
arately for the 15° and the 20° RA.
In order to address our second research question, we
first compared peak pressures between the group-
optimised design (defined above) and a personalised de-
sign. This personalised design was identified on an indi-
vidual participant basis as the apex position which
corresponded to the minimum peak pressures for that
participant. This comparison, between group-optimised
and personalised footwear, was carried out separately for
each rocker angle.
We then quantified the proportion of individuals for
which pressures were below the critical 200 kPa threshold
in both the group-optimised design and the personalised
design. Again, this was carried out separately for the two
different rocker angles in each anatomical region.
Finally, in order to understand whether footwear re-
sponses were similar between people with diabetes and
healthy individuals, we repeated the ANOVA analysis
(described above) on the healthy control subjects. We
also determined the group-optimised design for the
healthy group. In addition, to compare characteristics of
the two groups, the mean peak pressures (across all
eight rocker shoe designs) were compared between the
patients with diabetes and the healthy control group
using an independent t-test.
Results
A total of 102 individuals (52 male) with medically con-
firmed diagnosis of diabetes were recruited. These partici-
pant had a mean (SD) age of 57 (9 years), weight of 87
(18) Kg and height of 170 (9) cm. Loss of sensation at one
foot site was identified in 25 participants with and at 2 or
more sites in 17 participants (according to [20]). A further
66 healthy individuals (36 male) were recruited. There
were no differences in age, 56 (8) years or height, 173 (8)
cm between the healthy group and those with diabetes.
However, an independent t-test showed that the healthy
participants were of lower weight (p < 0.001, 74 (14) Kg).
There was a clear trend for pressure to increase as
apex position was moved distally (Fig. 2a-c, Table 1).
This effect was consistent across the three anatomical
regions but was most pronounced in the 2-4th MTH re-
gion, for which there were pairwise differences in peak
pressure between every apex position (Table 1). There
was also a significant main effect of rocker angle in each
anatomical region, with pressure decreasing as rocker
angle was increased from 15° to 20° (Fig. 2d-f, Table 1).
No interactions were observed in either the 1st MTP re-
gion or the hallux region (Table 1), showing that the ef-
fect of varying apex position was the same irrespective
of rocker angle. However, in the 2-4th MTH region, in-
creasing apex position angle from 62% to 67% lead to an
increase in pressure with the 15° but not the 20° rocker
angle (Fig. 2h, Table 1). Nevertheless, at the more prox-
imal apex positions (when there was lowest pressures),
the effect of changing apex position was consistent
across the two rocker angles (Fig. 2h).
The apex position at 52% of shoe length was found to
minimise peak pressures for the largest proportion of in-
dividuals for both rocker angles (Table 2). The one ex-
ception was in the hallux region with a 15° rocker angle
in which the 57% apex was shown to be optimal. Given
the consistency of the 52% apex position, this was se-
lected as the group-optimised design for all anatomical
regions and both rocker angles. Peak pressures were sig-
nificantly higher in the control shoe compared to the
group-optimised designs (Fig. 3, p < 0.001). This differ-
ence was most pronounced for the 2-4th MTH region,
for which the two group-optimised designs produced
30% and 37% reductions in peak pressure (for the
RA = 15° and 20° respectively, Fig. 3).
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There were only small differences in performance, be-
tween the group-optimised and personalised footwear,
within the context of the 200 kPa threshold. For ex-
ample, with a RA = 15°, the proportion of individuals
with pressures <200 kPa was only 4–6% larger with the
group-optimised design, compared to the personalised
design. Similar trends were observed with the 20° rocker
angle, however, interestingly, there was no increase in
the proportion of participants beneath the 200 kPa
threshold in the 2-4th MTH region (Table 3) with perso-
nalised footwear. Nevertheless, there was up to 12% in-
crease in the proportion of individuals under the
200 kPa threshold when the group-optimised 15° rocker
angle was compared to the group-optimised 20° rocker
angle design (Table 3). Table 3 also illustrates the pro-
portion of individuals with diabetes and peripheral neur-
opathy under the 200 kPa threshold. These data follow
similar trends to those of the full cohort of people with
diabetes, despite the fact that peak pressures (across all
the eight rocker shoe designs) were between 6 and 9 kPa
higher in the neuropathic (n = 17) compared to the non-
neuropathic group (n = 85).
When the ANOVA analysis was repeated on the
healthy participants, almost identical statistical trends
were observed. Specially, there were main effects of apex
position and rocker angle for every region with only the
2-4th MTH region showing an interaction (Fig. 2g-i).
The distribution of best apex positions also followed a
Fig. 2 The effect of varying apex position (a-c) and rocker angle (d-f) on peak plantar pressure under the 1st MTP, 2-4th MTH and Hallux in people
with diabetes (n = 102). The symbol * denotes a significant pairwise difference (p < 0.001) between a condition and at least one of the three other
apex positions (plots a-c) or other rocker angle (plots d-f). The vertical lines illustrate the standard deviations. Plots g-i show the interaction between
apex position and rocker angle (RA = 15° shown as dotted and RA = 20° shown as a dashed line) for the people with diabetes (black) and also for the
healthy individuals (red)
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similar pattern to that of the group with diabetes (Table 2),
illustrating the group-optimised design could also be identi-
fied from data on healthy individuals. Nevertheless, pres-
sures were higher in the group diabetes by 25% in the 1st
MTP region (p < 0.01) and 21% in the 2-4th MTH region
(p < 0.01).
Discussion
This study sought to understand the relationship between
peak plantar pressure and two rocker sole design features
in people with diabetes. The purpose was to use this un-
derstanding to propose a group-optimised shoe that could
be used to reduce pressures below 200 kPa and potentially
avoid the need for personalised footwear. The data identi-
fied that a stiff soled rocker shoe incorporating an apex
position at 52% of shoe length was optimal for pressure
reduction in three high-risk regions of the forefoot. Fur-
thermore, by combing this with a 20° rocker angle, peak
pressures were reduced below the 200 kPa threshold in a
large proportion (71–81%) of individuals with diabetes.
Importantly, the optimal apex of 52% was the same for all
three high-risk plantar regions. This design configuration
could therefore be appropriate for prefabricated footwear
and provided without the need for plantar pressure meas-
urement and personalisation of footwear design.
Based on requests in the literature [1] we focused on a
cohort with diabetes but no history of ulceration. This
relatively lower risk group are unlikely to choose footwear
which they deem to have an unacceptable appearance,
such as the extra-depth footwear sometimes advocated
post first ulceration [23]. Therefore, we sought to under-
stand the effect of decreasing rocker angle from 20° to 15°,
Table 1 ANOVA statistics, in each anatomical region, for the main effects of apex position, rocker angle and also for the interaction
1st MTP 2–4 MTH Hallux
Apex Position F = 18.2, p < 0.001* F = 157.1, p < 0.001* F = 35.7, p < 0.001*
52°-57° (−7.3, 3.5), p = 1.0 (−15.6, −9.1), p < 0.001* (−6.4, 3.2), p = 1.0
52°-62° (−12.2, 1.9), p = 0.32 (−32.9, −20.7), p < 0.001* (−12.8, −1.3), p = 0.008*
52°-67° (−23.4, −8.5), p < 0.001* (−39.0, −28.5), p < 0.001* (−28.4, −13.9), p < 0.001*
57°-62° (−9.4, 2.9), p = 0.97 (−18.9, −9.7), p < 0.001* (−11.6, 0.6), p = 0.10
57°-67° (−20.7, −7.3), p < 0.001* (−25.5, −17.2), p < 0.001* (−26.4, −12.7), p < 0.001*
62°-67° (−15.7, −5.9), p < 0.001* (−10.5, −3.4), p < 0.001* (−19.8, −8.3), p < 0.001*
Rocker Angle F = 67.4, p < 0.001* F = 179.5, p < 0.001* F = 76.2, p < 0.001*
15°-20° (9.8, 16.0) (10.9, 14.7) (11.1, 17.6)
Interaction F = 1.5, p = 0.22 F = 19.1, p < 0.001* F = 1.0, p = 0.41
Both the F-statistic and associated p-value have been reported. In addition, the 95% confidence intervals, and associated p-values, for the pairwise comparisons
between different apex positions are included. Note that these p-values have been adjusted using a Bonferroni correction for multiple comparisons. All statistical
differences (p < 0.01) have been marked with an *
Table 2 Distribution of best apex position (corresponding to minimum peak pressure) across the cohort for the two rocker angles
in each of the three anatomical regions
Participants with diabetes Healthy individuals
Apex position Rocker angle =15° Rocker angle = 20° Rocker angle =15° Rocker angle = 20°
1st MTP 52% 42% 46% 39% 56%
57% 30% 26% 39% 32%
62% 20% 23% 14% 9%
67% 8% 5% 8% 3%
2–4 MTH 52% 75% 87% 68% 88%
57% 19% 13% 23% 8%
62% 2% 0% 6% 5%
67% 5% 0% 3% 0%
Hallux 52% 25% 45% 33% 35%
57% 38% 25% 32% 41%
62% 30% 21% 27% 15%
67% 75 9% 8% 9%
Percentage values are provided for each apex position, with the group-optimised design (highest percentage) shown in bold. These data have been provided
separately for the participants with diabetes and also the health individuals
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as using this lower angle will produce footwear with a
thinner outsole that may be perceived as more acceptable
and may enhance adherence. The decrease in rocker angle
from 20° to 15° led to an decrease in the number of partic-
ipants beneath the critical threshold of 200 kPa (Table 3).
However, decreases were modest (6–12%) for the 1st
MTP and 2–4 MTH regions and small in the hallux re-
gion (5%). We therefore suggest that, if individuals are un-
willing to wear a shoe with a 20° rocker angle, then a 15°
could be prescribed as an acceptable alternative.
Through a series of two studies (this current study and
a previously published study [16]), we have attempted to
understand the combined effect of the three design fea-
tures of curved rocker footwear: apex angle, apex position
and rocker angle. Data from both these studies supports
the idea that increasing rocker angle will decrease plantar
pressures. However, there appears to be a complex rela-
tionship between apex angle and apex position. Whereas
in our first study, we investigated the effect of varying
apex position when apex angle was fixed at 80° [16], in this
current study apex angle was fixed at 95°. Interestingly, it
was not possible to specify a group-optimised apex pos-
ition in the previous study because of considerable inter-
subject variability. However, the use of a 95° apex angle
led to a much more consistent response in this current
work which supports the idea of a common footwear de-
sign for people with diabetes prior to first ulceration. This
group-optimised design would incorporate an apex angle
of 95°, an apex position of 52% of shoe length and a rocker
angle of 15° or 20°.
We sought to understand footwear performance in the
context of the 200 kPa threshold suggested by Owings et
al. [9]. This threshold was suggested based on mean in-
shoe pressures from individuals with a prior history of
ulceration who had remained ulcer free for a prolonged
period (0.4–14.4 years). The feet of those pre-first
Fig. 3 Comparison of peak plantar pressure between the control (Cntrl) shoe, the group-optimised design (apex position = 52%) and personalised
apex design (PersApex) in footwear with a rocker angle (RA) = 15° (a-c) and footwear with a RA = 20° (d-f) for the three anatomical regions. The
horizontal dotted line represents the 200 kPa threshold and the horizontal bars denote a significant difference between the control shoe and
group-optimised design (p < 0.001). Diabetes participants only
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ulceration are less likely to be at comparable risk of ul-
ceration. As such 200 kPa may be a conservative target
and, if the goal is to prevent primary ulceration, this tar-
get could perhaps be increased. Re-analysis of our data
with a revised threshold of 220 kPa (i.e. 10% higher
threshold) demonstrated a 5–7% decrease in the propor-
tion of feet at risk with the group-optimised design (for
example the percentage under the threshold increased
from 81% to 87% in the 2-4th MTH region). However,
importantly, the differences in the proportion of people
under the revised threshold between the group-
optimised design and the personalised design were very
similar to those observed with the 200 kPa threshold.
A clinical trial rather than a laboratory study is needed
to test the clinical efficacy of footwear for the prevention
of first ulceration. In their recent systematic review, Van
Netten et al. [1] advocated evaluating interventions on the
cohorts for which they are intended and, in the context of
interventions to prevent first ulceration, this would in-
volve individuals deemed at high risk of first ulceration. A
limitation of this current study is that most participants
would be considered low risk as they did not demonstrate
sensory loss. However, our cohort did include 17 who
demonstrated evidence of neuropathy and we quantified
the proportion of this subgroup for whom the group-
optimised rocker design reduced pressure beneath the
200 kPa threshold. These data showed very similar trends
(Table 3) compared to the full cohort with diabetes. This
provides some evidence that our proposed rocker design
may be appropriate, or at least a good starting point, for a
higher-risk population. Nevertheless, people with diabetes
can also present with deformity, Charcot arthropopathy,
or digit amputations, all of which will affect gait and foot
function. These may therefore influence the response to
footwear designs too. We acknowledge, therefore, that our
proposed design may not be immediately transferrable to
feet affected in different ways by diabetes.
It is important to recognise that even if the pattern of
response to the footwear designs is insensitive to diabetes,
elevated pressures, and neuropathy, as we suggest, the ac-
tual pressure values in people with neuropathy and at
higher risk would differ to those we report. This limitation
is important because the proportion of individuals over
the 200 kPa would likely be higher than we report. Never-
theless, as explained, 200 kPa is likely to be a conservative
target for those without prior ulceration and so the use of
the group-optimised footwear design would still decrease
the proportion of individuals considered at risk.
There are a number of other limitations to the current
study which should be highlighted. Firstly, due to the
practicalities of experimental testing, we chose to focus on
a specific shoe design, varying two specific design features
across a number of discrete levels. Our findings are there-
fore only valid for curved rocker footwear. Nevertheless,
our approach of systematically varying independent design
features in order to identify a group-optimised shoe design
could be applied in other footwear designs. A further limi-
tation is that we did not compare our group-optimised
footwear with fully customised footwear, incorporating an
extra depth upper along with a customised insole with
metatarsal pads and cut outs etc. However, the aim of this
study was to specify a group-optimised outsole design and
the beneficial effects of other footwear modifications are
likely to be additive. Such customised footwear comes at
greater cost, and perhaps lower adherence, and seems out
of context for the prevention of first ulceration, when
Table 3 The proportion of participants with a peak pressure below 200 kPa in the control shoe, the group-optimised design
(52% apex) and the personalised design (individually selected apex) for both the 15° and 20° rocker angles (RA), in each of
the three anatomical regions
Below 200 kPa
(RA = 15°)
Below 200 kPa
(RA = 20°)
Participants
with diabetes
(n = 102)
Participants with
diabetes and
peripheral neuropathy
(n = 17)
Participants with
diabetes (n = 102)
Participants with
diabetes and peripheral
neuropathy (n = 17)
1st MTP Control shoe 46% 35% 46% 35%
Group (52% apex) 66% 65% 74% 82%
Personalised apex 72% 71% 78% 82%
2–4 MTH Control shoe 13% 18% 13% 17%
Group (52% apex) 69% 53% 81% 76%
Personalised apex 73% 53% 81% 76%
Hallux Control shoe 60% 59% 60% 59%
Group (52% apex) 66% 65% 71% 71%
Personalised apex 70% 71% 75% 71%
Data are reported on all diabetes participants (n = 102) and also participants with diabetes and peripheral neuropathy (n = 17)
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most footwear is still sought via a retail route. However,
our proposed group-optimised design could be used as a
starting point for fully customised footwear if further re-
ductions in pressure were necessary.
Conclusions
By studying the relationship between footwear design
features and peak plantar pressure, we have been able to
suggest a group-optimised design for plantar pressure
reducing footwear. Our data demonstrate that this de-
sign can reduce pressures below the 200 kPa threshold
in the majority of people with elevated plantar pressure
but otherwise at low risk of first ulceration. The results
also show that personalised selection of footwear based
on collection of plantar pressure data may offer only
marginal gains in this population.
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